| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 163515-14-8 | 2-Chloro-N-(2,4-Dimethyl-3-Thienyl)-N-[(1S)-2-Methoxy-1-Methylethyl]-Acetamide | |
| 163515-35-3 | Chlorotoxin | C158H249N53O47S11 |
| 163517-56-4 | 2-(2-Methylphenyl)-1,3,2-Dioxaborinane | C10H13BO2 |
| 163517-61-1 | B-(3-Fluoro-2-Methylphenyl)-Boronic Acid | C7H8BFO2 |
| 163517-62-2 | 5-Fluoro-2-methylphenylboronic acid;5-Fluoro-2-methylbenzeneboronic acid; (5-Fluoro-2-methylphenyl)boronic acid | C7H8BFO2 |
| 163520-33-0 | 4,5-Dihydro-5,5-diphenyl-3-isoxazolecarboxylic acid ethyl ester;AE-F 122006; HOE 122006; Isoxadifen ethyl ester | C18H17NO3 |
| 163521-08-2 | Vilazodone hydrochloride;5-(4-(4-(5-Cyanoindol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide hydrochloride | C26H27N5O2.HCl |
| 163521-09-3 | 5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-2-benzofurancarboxylic acid ethyl ester hydrochloride | C28H30N4O3.2(HCl) |
| 163521-11-7 | 5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-2-benzofurancarboxylic acid ethyl ester | C28H30N4O3 |
| 163521-12-8 | Vilazodone;5-(4-(4-(5-Cyanoindol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide | C26H27N5O2 |
| 163521-19-5 | 5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-2-benzofurancarboxylic acid | C26H26N4O3 |
| 163521-20-8 | Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate | C15H18N2O3 |
| 163554-55-0 | 2-Methyl-2-Propanyl (1-Formylcyclobutyl)Carbamate | C10H17NO3 |
| 163556-04-5 | 3,5-Diformyl-1-indolizinecarboxylic acid methyl ester | C12H9NO4 |
| 163558-30-3 | Fmoc-S-sulfo-L-cysteine disodium salt;N-((9H-fluoren-9-ylmethoxy)carbonyl)-S-sulfo-L-cysteine disodium salt | C18H15NNa2O7S2 |
| 163563-64-2 | 2-Chloro-6-phenylnicotinonitrile;2-Chloro-4-phenyl-3-pyridinecarbonitrile | C12H7ClN2 |
| 163596-56-3 | (E)-1-(3-Phenyl-2-propenyl)piperazine dihydrochloride | C13H18N2.2(HCl) |
| 163596-75-6 | 4-Bromo-3-nitrobenzaldehyde | C7H4BrNO3 |
| 163597-57-7 | 3-Cyano-4-isobutyloxythiobenzamide;3-Cyano-4-(2-methylpropoxy)benzenecarbothioamide | C12H14N2OS |
| 163619-04-3 | Fmoc-D-Trp(Boc)-OH;N-alpha-Fmoc-N(in)-Boc-D-tryptophan; N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-in-tert-butyl-oxycarbonyl-D-tryptophan | C31H30N2O6 |
| 163620-24-4 | 2-(1-Methylhydrazino)-5-(trifluoromethyl)pyridine | C7H8F3N3 |
| 163630-79-3 | 1'-(4-(1-(4-Fluorophenyl)-1H-indol-3-yl)butyl)-spiro(isobenzofuran-1(3H),4'-piperidine) (E)-2-butenedioate (1:1) | C30H31FN2O.C4H4O4 |
| 163655-37-6 | (3Z)-3-{[4-(Dimethylamino)-1-Naphthyl]Methylene}-1,3-Dihydro-2H-Indol-2-One | C21H18N2O |
| 163658-33-1 | (6-Ethylpyridin-2-yl)methanol | C8H11NO |
| 163679-35-4 | 2,5-Dioxo-1-Pyrrolidinyl 3,5-Diiodo-N-{[(2-Methyl-2-Propanyl)Oxy]Carbonyl}-L-Tyrosinate | C18H20I2N2O7 |
| 163680-77-1 | Pazufloxacin mesilate;Pazufloxaxin methanesulfonate; (3S)-10-(1-Aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid methanesulfonate | C16H15FN2O4.CH4O3S |
| 163685-38-9 | 1-(2-(2-Methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol | C15H25NO3 |
| 163702-05-4 | (Perfluorobutoxy)ethane;1-Ethoxynonafluorobutane; CF 76; Cosmetic Fluid CF 76; Ethyl nonafluorobutyl ether; Ethyl perfluorobutyl ether; HFE 569mccc; HFE 569sf2; HFE 7200; Nonafluorobutyl ethyl ether; Novec 7200; Novec HFE 7200 | C6H5F9O |
| 163702-07-6 | Methyl nonafluorobutyl ether;Perfluorobutyl methyl ether; Methyl 1,1,2,2,3,3,4,4,4-nonafluorobutyl ether | C5H3F9O |
| 163702-08-7 | 1,1,2,3,3,3-Hexafluoro-1-methoxy-2-(trifluoromethyl)propane;2-(Difluoromethoxymethyl)-1,1,1,2,3,3,3-heptafluoropropane; Methyl nonafluoroisobutyl ether; Methyl perfluoroisobutyl ether; Perfluoroisobutyl methyl ether; i 7100 | C5H3F9O |
| 163704-47-0 | 2-Iodo-1,3-diisopropylbenzene | |
| 163706-06-7 | Cangrelor;AR-C 69931; N-(2-(Methylthio)ethyl)-2-((3,3,3-trifluoropropyl)thio)-5'-adenylic acid anhydride with P,P'-(dichloromethylene)bis(phosphonic acid) | C17H25Cl2F3N5O12P3S2 |
| 163706-36-3 | Cangrelor tetrasodium;AR-C 69931MX | C17H21Cl2F3N5O12P3S2.Na4 |
| 163706-51-2 | 2-((3,3,3-Trifluoropropyl)thio)adenosine | C13H16F3N5O4S |
| 163706-58-9 | N-(2-(Methylthio)ethyl)-2-((3,3,3-trifluoropropyl)thio)adenosine | C16H22F3N5O4S2 |
| 163706-61-4 | (Dichloromethylene)bis(phosphonic acid) mono(tributylamine) salt | C12H27N.CH4Cl2O6P2 |
| 163719-69-5 | Ethyl 3-(4-Chlorophenyl)-1,2,4-Oxadiazole-5-Carboxylate | C11H9ClN2O3 |
| 163719-70-8 | Ethyl 3-Isopropyl-1,2,4-Oxadiazole-5-Carboxylate | C8H12N2O3 |
| 163719-72-0 | Ethyl 3-(4-Pyridinyl)-1,2,4-Oxadiazole-5-Carboxylate | C10H9N3O3 |
| 163719-76-4 | Ethyl 3-(2-Pyridinyl)-1,2,4-Oxadiazole-5-Carboxylate | C10H9N3O3 |
| 163719-78-6 | 5-Ethenyl-1,2,4-oxadiazole-3-carboxylic acid ethyl ester | C7H8N2O3 |
| 163719-80-0 | Ethyl 3-(4-Pyridinyl)-1,2,4-Oxadiazole-5-Carboxylate | C10H9N3O3 |
| 163719-81-1 | Ethyl 3-(4-Fluorophenyl)-1,2,4-Oxadiazole-5-Carboxylate | C11H9FN2O3 |
| 163725-12-0 | 2-[(2-Cyanophenyl)Sulfanyl]Benzoic Acid | C14H9NO2S |
| 163733-96-8 | 3,4,5-Trifluoroaniline | C6H4F3N |
| 163733-99-1 | 4-Amino-2,3-difluorophenol | C6H5F2NO |
| 163734-01-8 | 2-Amino-4,5-difluorophenol | C6H5F2NO |
| 163759-49-7 | 2'-O-(2-Methoxyethyl)-5-methyluridine;1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl)-5-methylpyrimidine-2,4-dione | C13H20N2O7 |
| 163759-50-0 | 5'-O-(Bis(4-methoxyphenyl)phenylmethyl)-2'-O-(2-methoxyethyl)-5-methyluridine;1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)-phenylmethoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)oxolan-2-yl)-5-methylpyrimidine-2,4-dione | C34H38N2O9 |
| 163759-94-2 | N-Benzoyl-5'-O-(bis(4-methoxyphenyl)phenylmethyl)-2'-O-(2-methoxyethyl)-5-methylcytidine 3'-(2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite) | C50H60N5O10P |